By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Versartis, Inc.  

275 Shorline Drive
Suite 450
Redwood City  California  94065  U.S.A.
Phone: 650-963-8588 Fax: n/a



Start Up

Company News
Amunix, Inc. Congratulates Versartis, Inc. (VSAR) On Its Positive Phase 2a Results With VRS-317 6/30/2014 11:13:03 AM
Versartis, Inc. (VSAR) Presents Positive Six Month VRS-317 Phase 2a Clinical Study Results 6/24/2014 8:33:49 AM
Versartis, Inc. (VSAR) Appoints Endocrinologist Bert Bakker, MD, PhD, As Senior Vice President, Medical Affairs 6/23/2014 7:31:44 AM
Versartis, Inc. (VSAR) To Hold Conference Call To Discuss Six Month VRS-317 Phase 2a VERTICAL Clinical Trial Results 6/9/2014 9:01:09 AM
Versartis, Inc. (VSAR) Selects Comprehend Systems 5/19/2014 10:03:21 AM
Versartis, Inc. (VSAR) Reports First Quarter 2014 Financial Results 5/5/2014 8:56:49 AM
Versartis, Inc. (VSAR) Announces Closing Of Its Initial Public Offering And Full Exercise Of Over-Allottment Option 3/27/2014 9:28:26 AM
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014 7:13:53 AM
Tall Order: Growth Hormone Developer Versartis, Inc. Seeks $80 Million IPO 2/19/2014 7:42:11 AM
Bay Area's Versartis, Inc. Secures $55 Million Series E Financing 2/18/2014 7:20:10 AM